» Articles » PMID: 30935031

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles

Overview
Journal Nutrients
Date 2019 Apr 3
PMID 30935031
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcopenic obesity (OSO) syndrome describes the simultaneous deterioration of bone, muscle and excess fat, resulting in reduced functionality and systemic metabolic dysregulation. The key component contributing to this may be ectopic fat in the viscera, bone and muscle. OSO research to date is summarized, and the revised criteria for its identification for research purposes are reviewed and proposed, including new criteria to assess visceral fat in males and females. Finally, nutritional and physical activity recommendations are consolidated into a treatment algorithm, which can be validated in future studies and which may also be applied to preventative management.

Citing Articles

Body composition and nutritional status in nursing home residents during the COVID-19 lockdown: a 15-month follow-up.

Cvijetic S, Keser I, Ilich J Arh Hig Rada Toksikol. 2024; 75(4):283-288.

PMID: 39718092 PMC: 11667791. DOI: 10.2478/aiht-2024-75-3886.


What Is the Best Method for Diagnosing Osteosarcopenic Adiposity in Women After Long-Term Bariatric Surgery? A Comparison and Validation of Different Criteria.

Araujo M, Lima R, Baiocchi de Carvalho K, Botelho P Nutrients. 2024; 16(22).

PMID: 39599750 PMC: 11597721. DOI: 10.3390/nu16223965.


MRI-Based Phenotyping for Osteosarcopenic Adiposity in Subjects from a Population-Based Cohort.

Maurer E, Rospleszcz S, Rathmann W, Thorand B, Peters A, Schlett C Geriatrics (Basel). 2024; 9(6).

PMID: 39584951 PMC: 11587111. DOI: 10.3390/geriatrics9060150.


Investigation of Nutritional Factors and Malnutrition Risk Prediction Model in Hospitalized Patients with Systemic Lupus Erythematosus in China.

Xia L, Yang F, Hayashi N, Ma Y, Yan B, Du Y J Inflamm Res. 2024; 17:8891-8904.

PMID: 39575346 PMC: 11579133. DOI: 10.2147/JIR.S486792.


Bergamot (), a (Poly)Phenol-Rich Source for Improving Osteosarcopenic Obesity: A Systematic Review.

Mazzola G, Rondanelli M, Baron G, Zupo R, Castellana F, Clodoveo M Foods. 2024; 13(21).

PMID: 39517207 PMC: 11545342. DOI: 10.3390/foods13213422.


References
1.
Li Z, Heber D . Sarcopenic obesity in the elderly and strategies for weight management. Nutr Rev. 2012; 70(1):57-64. DOI: 10.1111/j.1753-4887.2011.00453.x. View

2.
Rom O, Kaisari S, Aizenbud D, Reznick A . Lifestyle and sarcopenia-etiology, prevention, and treatment. Rambam Maimonides Med J. 2013; 3(4):e0024. PMC: 3678825. DOI: 10.5041/RMMJ.10091. View

3.
Inglis J, Ilich J . The Microbiome and Osteosarcopenic Obesity in Older Individuals in Long-Term Care Facilities. Curr Osteoporos Rep. 2015; 13(5):358-62. DOI: 10.1007/s11914-015-0287-7. View

4.
Newman A, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M . Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51(11):1602-9. DOI: 10.1046/j.1532-5415.2003.51534.x. View

5.
Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View